Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain

(2020) Antoni Sicras-Mainar et al.   JOURNAL OF MEDICAL ECONOMICS

The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization

(2019) A. Viinanen et al.   JOURNAL OF ASTHMA

Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan

(2019) Hiroyuki Nagase et al.   ALLERGOLOGY INTERNATIONAL

Different endotypes and phenotypes drive the heterogeneity in severe asthma

(2019) P. Jane McDowell et al.   ALLERGY

Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline

(2019) Fernando Holguin et al.   EUROPEAN RESPIRATORY JOURNAL

Severe asthma phenotypes and endotypes

(2019) Ioana Agache   SEMINARS IN IMMUNOLOGY

Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review

(2019) Cíntia Bassani et al.   Revista da Associacao Medica Brasileira

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

(2019) Giancarlo Marone et al.   Frontiers in Pharmacology

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

(2018) Klaus F. Rabe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

(2018) Mario Castro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment

(2018) Stephanie Chen et al.   CURRENT MEDICAL RESEARCH AND OPINION

Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials

(2018) Yazan Zayed et al.   JOURNAL OF ASTHMA

Clinical and economic burden of severe asthma: A French cohort study

(2018) Clementine Nordon et al.   RESPIRATORY MEDICINE

Methods for including information from multi-arm trials in pairwise meta-analysis

(2017) Gerta Rücker et al.   Research Synthesis Methods

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

(2016) Sally Wenzel et al.   LANCET

External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthma

(2014) A H Wagener et al.   THORAX

Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects

(2013) Annette T. Hastie et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk

(2013) Ana Bobinac et al.   PHARMACOECONOMICS

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

(2011) Raed A. Dweik et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

GRADE guidelines: 9. Rating up the quality of evidence

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

(2009) Takeru Shiroiwa et al.   HEALTH ECONOMICS

Economic Evaluations in the EURONHEED

(2009) Florencia Hutter et al.   PHARMACOECONOMICS

Undue reliance on I 2 in assessing heterogeneity may mislead

(2008) Gerta Rücker et al.   BMC Medical Research Methodology

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal